This podcast currently has no reviews.
Submit ReviewThis podcast currently has no reviews.
Submit ReviewVikash Gilja is an assistant professor at UCSD, where he researchers brain-machine interfaces. Dr. Gilja is an advisor to Paradromics. He holds a Ph.D. in computer science from Stanford University, an M.Eng and B.S. in EECS from MIT, and a B.S. in brain and cognitive sciences from MIT.
Rob Edgington is the head of AI at Paradromics. He holds a Ph.D. in brain-machine interfaces from UCL, and an M.Phys in physics from the University of Oxford.
Konrad Kording is a full professor at the University of Pennsylvania, where he works on data problems in neuroscience. He holds a Ph.D. in physics from ETH Zurich.
Marc Ferro is a post-doctoral researcher at Stanford University. Marc holds a Ph.D. from École des Mines de Saint-Étienne and an undergraduate degree from École nationale supérieure des Mines de Saint-Étienne.
Gordon Wilson is the CEO of neuromorphics.com/">Rain Neuromorphics, a company developing neuromorphic computer chips to enable brain-like artificial intelligence. Gordon holds a B.S. in Statistics and Mathematics from the University of Florida.
Dr. Alik Widge is an Assistant Professor at the University of Minnesota, where he is a practicing psychiatrist and conducts research in applying neurotechnology to psychiatric disorders. Alik holds a B.A. in computer science and cognitive science from Dartmouth College, a Ph.D. in robotics from Carnegie Mellon University, and an M.D. from the University of Pittsburgh School of Medicine.
Brian Pepin is the CEO and founder of Rune Labs. Brian holds an MSEE in electrical engineering from UC Berkeley and a BSEE from the University of Washington. Prior to starting Rune, Brian spent nearly five years at Verily Life Sciences.
Jeff June is the founder and CEO of IschemiaCare. Jeff comes from a background in venture capital and private equity, and held the Forsythe Chair in Entrepreneurship at Miami University of Ohio.
Tom Hughes is the Senior Principal Advisor in Healthcare Economics and Reimbursement at inc.com/">Regulatory and Clinical Research Institute, Inc. He holds a J.D. from William Mitchell College of Law, and an undergraduate degree from the University of Minnesota-Twin Cities.
Disclaimer: We actively write about the themes in which we invest: artificial intelligence, robotics, virtual reality, and augmented reality. From time to time, we will write about companies that are in our portfolio. Content on this site including opinions on specific themes in technology, market estimates, and estimates and commentary regarding publicly traded or private companies is not intended for use in making investment decisions. We hold no obligation to update any of our projections. We express no warranties about any estimates or opinions we make.
Cory Inman is a Post Doctoral Fellow at Emory University’s Department of Neurosurgery, where he studies human memory and emotion. Cory holds a B.A. in Experimental Psychology from Georgia State University, and a Ph.D. in Psychology and M.A. in Psychology and Cognitive Neuroscience from Emory University.
Disclaimer: We actively write about the themes in which we invest: artificial intelligence, robotics, virtual reality, and augmented reality. From time to time, we will write about companies that are in our portfolio. Content on this site including opinions on specific themes in technology, market estimates, and estimates and commentary regarding publicly traded or private companies is not intended for use in making investment decisions. We hold no obligation to update any of our projections. We express no warranties about any estimates or opinions we make.
Mary Beth Henderson is the VP of Regulatory Affairs and Quality Systems at inc.com/">Regulatory and Clinical Research Institute, Inc. She holds a B.A. in Chemistry from Gustavus Adolphus College, an M.S. and Ph.D. in Chemistry from Northwestern University, and an MBA from the University of Massachusetts at Lowell.
Disclaimer: We actively write about the themes in which we invest: artificial intelligence, robotics, virtual reality, and augmented reality. From time to time, we will write about companies that are in our portfolio. Content on this site including opinions on specific themes in technology, market estimates, and estimates and commentary regarding publicly traded or private companies is not intended for use in making investment decisions. We hold no obligation to update any of our projections. We express no warranties about any estimates or opinions we make.
Iris Coates McCall is a Neurotechnology Researcher at Neuroethics Canada, University of British Columbia. Iris holds a Bachelors of Arts and Science in Cognitive Science from McGill University, and a Masters of Bioethics from Johns Hopkins.
Disclaimer: We actively write about the themes in which we invest: artificial intelligence, robotics, virtual reality, and augmented reality. From time to time, we will write about companies that are in our portfolio. Content on this site including opinions on specific themes in technology, market estimates, and estimates and commentary regarding publicly traded or private companies is not intended for use in making investment decisions. We hold no obligation to update any of our projections. We express no warranties about any estimates or opinions we make.
This podcast could use a review! Have anything to say about it? Share your thoughts using the button below.
Submit Review